| Product Code: ETC10223221 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Latvia continued to see a high concentration of import shipments for prostate-specific antigen blood-based biomarkers, with top exporting countries being Metropolitan France, Germany, Lithuania, Poland, and the USA. Despite a significant decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) from 2020 to 2024 remained impressive at 43.42%. This indicates a steady demand for these biomarkers in Latvia, with key importing countries maintaining their strong presence in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market - Industry Life Cycle |
3.4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market - Porter's Five Forces |
3.5 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Test Sensitivity, 2021 & 2031F |
3.8 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Distribution, 2021 & 2031F |
4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about prostate cancer screening and early detection methods |
4.2.2 Growing prevalence of prostate cancer in Latvia |
4.2.3 Technological advancements in blood-based biomarker testing |
4.3 Market Restraints |
4.3.1 Regulatory hurdles and compliance requirements for diagnostic testing |
4.3.2 Limited healthcare infrastructure and resources in certain regions of Latvia |
5 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Trends |
6 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market, By Types |
6.1 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Application, 2021 - 2031F |
6.1.3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Testing, 2021 - 2031F |
6.1.4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Screening, 2021 - 2031F |
6.1.5 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Prognostic Testing, 2021 - 2031F |
6.1.6 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Monitoring, 2021 - 2031F |
6.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Serum PSA, 2021 - 2031F |
6.2.3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Free PSA, 2021 - 2031F |
6.2.4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Total PSA, 2021 - 2031F |
6.2.5 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Complex PSA, 2021 - 2031F |
6.3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market, By Test Sensitivity |
6.3.1 Overview and Analysis |
6.3.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By High Sensitivity, 2021 - 2031F |
6.3.3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Low Sensitivity, 2021 - 2031F |
6.3.4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Specificity, 2021 - 2031F |
6.4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market, By Distribution |
6.5.1 Overview and Analysis |
6.5.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Direct-to-Consumer, 2021 - 2031F |
6.5.3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Import-Export Trade Statistics |
7.1 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Export to Major Countries |
7.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Imports from Major Countries |
8 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Key Performance Indicators |
8.1 Adoption rate of PSA blood-based biomarker testing by healthcare providers |
8.2 Number of prostate cancer cases diagnosed at an early stage |
8.3 Percentage of healthcare facilities offering PSA blood-based biomarker testing |
9 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market - Opportunity Assessment |
9.1 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Test Sensitivity, 2021 & 2031F |
9.4 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.5 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Distribution, 2021 & 2031F |
10 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market - Competitive Landscape |
10.1 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Revenue Share, By Companies, 2024 |
10.2 Latvia Prostate-Specific Antigen Blood-Based Biomarker Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here